Home > Insider Trading > Filing (0001104659-16-130147)

Filing Details

Accession Number:: 0001104659-16-130147
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-29 16:46:35
Reporting Period:: 2016-06-27

Filing Date:: 2016-06-29
Accepted Time:: 2016-06-29 16:46:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1453687	Selecta Biosciences Inc	SELB	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1677406	Ltd Management Nanodimension	Governor'S Square, Unit 3-213-62 23 Lime Tree Bay Ave Grand Cayman E9 KY1-1302		No	No	Yes	No
1677409	Partnership Limited Nanodimension	Governor'S Square, Unit 3-213-62 23 Lime Tree Bay Ave Grand Cayman E9 KY1-1302		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-27	637,790	$0.00	660,957	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2016-06-27	385,000	$14.00	1,045,957	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2016-06-27	315,729	$0.00	315,729	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2016-06-27	94,183	$0.00	94,183	$0.00
Common Stock	Series D Convertible Preferred Stock	Disposition	2016-06-27	83,596	$0.00	83,596	$0.00
Common Stock	Series E Convertible Preferred Stock	Disposition	2016-06-27	93,078	$0.00	144,282	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Held by NanoDimension L.P. ("ND LP).
Consists of 660,957 shares held by ND LP, 350,000 shares held by NanoDimension L.P. II ("NDLP2") and 35,000 shares held by NanoDimension Management Limited ("ND GP").
ND GP serves as the general partner of ND LP and possesses the power to direct the voting and disposition of the shares owned by ND LP and may be deemed to have indirect beneficial ownership of the shares held by ND LP. NanoDimension II Mangement Limited ("NDGP2") serves as the general partner of NDLP2 and possesses the power to direct the voting and disposition of the shares owned by NDLP2 and may be deemed to have indirect beneficial ownership of the shares held by NDLP2. ND GP and NDGP2 disclaim beneficial ownership of such shares, except to the extent of their pecuniary interest therein. Jonathan Nicholson and Richard Coles are the members of the board of directors of ND GP and NDGP2 and share voting and dispositive power over the shares held by ND LP and NDLP2. Each reporting person disclaims beneficial ownership of the securities reported herein, except to the extent of their respective pecuniary interest therein.
The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock automatically converted into common stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.
The Series E Convertible Preferred Stock is convertible at any time, at the holder's election and has no expiration date. The Series E Convertible Preferred Stock automatically converted into common stock on an approximately 1-for-1.550115 basis upon the closing of the Issuer's initial public offering.